Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net sales	$ 1,695.9	$ 1,566.5	$ 1,530.5
Cost of sales	931.1	859.5	882.4
Gross profit	764.8	707.0	648.1
Selling, general and administrative expenses	417.6	389.8	371.3
Restructuring and other similar charges	9.6	13.5	15.3
Loss on divestiture of asbestos liabilities and certain assets	0.0	0.0	11.4
Amortization of intangible assets	58.7	59.1	58.7
Income from operations	278.9	244.6	191.4
Non-operating expense:
Interest expense, net	(28.6)	(33.1)	(38.5)
Loss on the extinguishment of debt	0.0	0.0	(0.9)
Actuarial gain on pension and other postretirement benefit obligations	0.5	1.4	2.0
Other income (expense), net	5.5	(5.9)	(7.2)
Income before income taxes	256.3	207.0	146.8
Provision for income taxes	(63.9)	(48.1)	(42.6)
Net income from continuing operations	192.4	158.9	104.2
Income from discontinued operations, net of tax	5.6	1.3	8.5
Net income	$ 198.0	$ 160.2	$ 112.7
Basic net income per share:
Continuing operations (in dollars per share)	$ 1.14	$ 0.92	$ 0.60
Discontinued operations (in dollars per share)	0.03	0.01	0.05
Net income (in dollars per share)	1.17	0.93	0.65
Diluted net income per share:
Continuing operations (in dollars per share)	1.12	0.91	0.59
Discontinued operations (in dollars per share)	0.03	0.01	0.05
Net income (in dollars per share)	$ 1.15	$ 0.92	$ 0.64
Weighted-average number of common shares outstanding (in thousands):
Basic (in shares)	168,659	171,686	174,251
Effect of dilutive equity awards (in shares)	2,599	2,973	3,008
Diluted (in shares)	171,258	174,659	177,259